HOME > LATEST
LATEST
-
BUSINESS Daridorexant Hits Primary Goal in South Korea PIII Insomnia Trial, Nxera Plans Filing in Q1 2026
January 20, 2026
-
BUSINESS Enhertu Combo Accepted for EU Review in First-Line HER2 Breast Cancer
January 20, 2026
-
REGULATORY Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead
January 19, 2026
-
REGULATORY Chuikyo OKs 3.5% Minimum NHI Price Hike, Sets Grace Period for New AG Pricing
January 19, 2026
-
BUSINESS Oncolys Aims for First-Line Use of Telomelysin in Esophageal Cancer
January 19, 2026
-
REGULATORY Antivirals, Cancer Drugs Flagged in PMDA Risk Review
January 19, 2026
-
BUSINESS 3D Plans to Lift Toho Stake to Up to 27%
January 19, 2026
-
BUSINESS Nobelpharma Launches Pediatric Sleep Aid Melatonin in China
January 19, 2026
-
REGULATORY Bosulif, 4 Other Drugs Escape April Re-Pricing as “Spillover” Scrapped; Lixiana, Entresto Brace for Cuts
January 19, 2026
-
REGULATORY Japan Panel to Review Pfizer’s Cancer Med Tukysa on January 29
January 16, 2026
-
REGULATORY Japan Sets New Pricing Rules for Conditionally Approved Regenerative Medicines, Starting with Elevidys
January 15, 2026
-
BUSINESS Takeda’s TYK2 Inhibitor Scores PIII Win in Psoriasis Trials
December 19, 2025
-
REGULATORY LDP Tax Panel OKs New 40% R&D Credit for Strategic Technologies
December 12, 2025
-
BUSINESS AG Price Parity Plan Stokes Industry Fears of Patient, Pharmacy Defections
December 12, 2025
-
BUSINESS Kyowa Kirin Names Abdul Mullick as Next CEO from March 2026
December 12, 2025
-
BUSINESS Regeneron Files Libtayo for Squamous Cell Carcinoma in Japan
December 12, 2025
-
BUSINESS Chugai to Donate 100 Million Yen to Support Nobel Laureate Sakaguchi’s Research
December 12, 2025
-
REGULATORY Pharma Renews Call to Scrap “Spillover,” “Huge-Seller” Rules as FY2026 Talks Enter Final Stretch
December 11, 2025
-
BUSINESS Regeneron Lines Up 5 Late-Stage Assets for Japan: Commercial Head
December 11, 2025
-
REGULATORY 2024 Reform Spurred New Development Activity, 20 Projects Entered Clinic: Industry Poll
December 11, 2025
ページ
The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…
